High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. (1st October 2014)

• Record Type: Journal Article
• Authors: Colucci, R.; Lotti, F.; Dragoni, F.; Arunachalam, M.; Lotti, T.; Benvenga, S.; Moretti, S.
• Is Part Of: British journal of dermatology. Volume 171:Number 4(2014:Oct.)
• Page Start: 786
• Page End: 798
• Publication Date: 2014-10-01
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.13286
• Languages: English
• ISSNs: 0007-0963

Abstract

<abstract abstract-type="short" xml:lang="en" id="bjd13286-abs-0002"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>What's already known about this topic?</bold> </p> <p> <list id="bjd13286-list-0001" list-type="bullet"> <list-item> <p>Vitiligo is strongly associated with autoimmune thyroid disorders.</p> </list-item> <list-item> <p>Autoantibodies against thyroid hormones (THAbs) have a very low prevalence in the general population and are increased in thyroid and extrathyroid autoimmune diseases.</p> </list-item> </list> </p> <p> <bold>What does this study add?</bold> </p> <p> <list id="bjd13286-list-0002" list-type="bullet"> <list-item> <p>For the first time, THAbs against triiodothyronine (T3‐Ab) and thyroxine (T4‐Ab) have been detected in a group of patients with vitiligo.</p> </list-item> <list-item> <p>T3‐Ab and T4‐Ab were associated with some clinical and historical parameters of vitiligo.</p> </list-item> </list> </p> </abstract>